Indobufen induced modification of phospholipid composition in diabetic platelets. 1996

A Dmoszyńska, and B Sokołowska, and A Walter-Croneck, and K Przesmycki, and A Ledwozyw
Department of Haematology, Medical Academy, Lublin, Poland.

The influence of indobufen (200 mg twice daily for 10 days) on platelet lipid peroxidation and phospholipid metabolism in diabetic patients was investigated. We have studied 18 patients with type I of diabetes mellitus. The duration of disease varied between 3 and 25 years (average 11 years). All patients showed symptoms of diabetic angiopathy. Investigations were carried out after restoring the carbohydrate balance. The following tests were performed before and after a 10 day treatment with indobufen: malondialdehyde, conjugated dienes and lipid hydroperoxides, phospholipids, fatty acids. We observed a significantly higher production of lipid peroxidation products in diabetic platelets compared to control platelets. After a 10 day treatment with indobufen the intensity of peroxidation lowered significantly. The phospholipid composition of diabetic platelets showed a significant increase in lysophosphoglycerides fraction compared to the control platelets. After the indobufen treatment a significant decrease in sphingomyelin content was observed. In other phospholipid fractions no significant differences were observed.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010654 Phenylbutyrates Derivatives of 4-phenylbutyric acid, including its salts and esters.
D010712 Phosphatidic Acids Fatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups. Ammonium Phosphatidate,Diacylglycerophosphates,Phosphatidic Acid,Acid, Phosphatidic,Acids, Phosphatidic,Phosphatidate, Ammonium
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003925 Diabetic Angiopathies VASCULAR DISEASES that are associated with DIABETES MELLITUS. Diabetic Vascular Complications,Diabetic Vascular Diseases,Microangiopathy, Diabetic,Angiopathies, Diabetic,Angiopathy, Diabetic,Diabetic Angiopathy,Diabetic Microangiopathies,Diabetic Microangiopathy,Diabetic Vascular Complication,Diabetic Vascular Disease,Microangiopathies, Diabetic,Vascular Complication, Diabetic,Vascular Complications, Diabetic,Vascular Disease, Diabetic,Vascular Diseases, Diabetic
D005260 Female Females

Related Publications

A Dmoszyńska, and B Sokołowska, and A Walter-Croneck, and K Przesmycki, and A Ledwozyw
September 1995, Thrombosis research,
A Dmoszyńska, and B Sokołowska, and A Walter-Croneck, and K Przesmycki, and A Ledwozyw
May 1985, Thrombosis research,
A Dmoszyńska, and B Sokołowska, and A Walter-Croneck, and K Przesmycki, and A Ledwozyw
March 1983, British medical journal (Clinical research ed.),
A Dmoszyńska, and B Sokołowska, and A Walter-Croneck, and K Przesmycki, and A Ledwozyw
January 1983, British medical journal (Clinical research ed.),
A Dmoszyńska, and B Sokołowska, and A Walter-Croneck, and K Przesmycki, and A Ledwozyw
April 1978, Clinical biochemistry,
A Dmoszyńska, and B Sokołowska, and A Walter-Croneck, and K Przesmycki, and A Ledwozyw
January 1991, Nauchnye doklady vysshei shkoly. Biologicheskie nauki,
A Dmoszyńska, and B Sokołowska, and A Walter-Croneck, and K Przesmycki, and A Ledwozyw
August 1976, Biochimica et biophysica acta,
A Dmoszyńska, and B Sokołowska, and A Walter-Croneck, and K Przesmycki, and A Ledwozyw
September 1992, Prostaglandins, leukotrienes, and essential fatty acids,
A Dmoszyńska, and B Sokołowska, and A Walter-Croneck, and K Przesmycki, and A Ledwozyw
June 1991, Biochimica et biophysica acta,
A Dmoszyńska, and B Sokołowska, and A Walter-Croneck, and K Przesmycki, and A Ledwozyw
June 1986, Journal of neurochemistry,
Copied contents to your clipboard!